Kodiak Sciences Inc
Research Kodiak Sciences Inc (KOD) on Bullrun: market cap USD 2.36B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKOD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.36B
- Financial periodFY2025
- Net income-USD 229.97M
- Free cash flow-USD 136.51M
Valuation Snapshot
latest market cap is USD 2.36B.
About Kodiak Sciences Inc
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases;
Frequently asked questions
What is Kodiak Sciences Inc's market cap?
Kodiak Sciences Inc's market capitalization is USD 2.36B.
What does Kodiak Sciences Inc do?
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.